tirzepatide hot flashes Menopause, & HRT: The Metabolic “Multiplier" In the OASIS-3 phase 3

GLP-1 drugs are primarily recommended for: Adults with type 2 diabetes who arent seeing results from oral medications and need better blood sugar control People with obesity or with a BMI over 30 (with or without diabetes) seeking medical weight management Doctors may also consider GLP-1 RAs for patients with cardiovascular risk factors, as some of these drugs have shown heart-protective benefits

With its expanding reach and growing recognition, WEGOVY is redefining the future of obesity treatments

Provided herein in one embodiment are otic formulations and compositions comprising triglycerides

Tirzepatide frequently causes nausea (12-22% of patients), diarrhea (12-16%), vomiting (6-10%), constipation (6-7%), and abdominal discomfort, particularly during dose escalation

BNIP3 and NIX facilitate the targeting of mitochondria to autophagosomes through direct interactions with LC3, which is located on the cytosolic surface of autophagosomal membranes, utilizing both typical and atypical LIR motifs [35]